Component-resolved allergy diagnosis: a new era?

Area of Science:

• Immunology
• Allergy Diagnostics
• In Vitro Assays

Background:

• Traditional allergy diagnosis relies on whole allergen extracts.
• Component-resolved allergy diagnosis (CRD) utilizes purified or recombinant allergen components.
• CRD quantifies specific IgE (sIgE) antibodies to individual proteins.

Purpose of the Study:

• To introduce and evaluate component-resolved allergy diagnosis (CRD) as a novel in vitro technique.
• To compare CRD with traditional specific IgE (sIgE) assays.
• To assess the potential of CRD in improving allergic patient management.

Main Methods:

• Quantification of sIgE antibodies to single protein components.
• Utilizing purified native or recombinant allergen components.
• Comparison with traditional sIgE assays based on whole extracts.

Main Results:

• CRD allows for discrimination between clinically relevant and irrelevant sIgE results.
• CRD can establish sensitization patterns with prognostic value.
• CRD shows potential to improve allergic patient management.

Conclusions:

• Component-resolved allergy diagnosis (CRD) is an emerging in vitro technique for allergy diagnosis.
• CRD may enhance patient management by identifying significant allergen components.
• Further clinical validation is required before CRD can be widely adopted or replace traditional sIgE assays.